An Irish woman who headed Ireland’s medicine’s watchdog has been appointed to take over as Executive Director of the European ...

GILD wins FDA approval for Yeztugo, the first and only twice-yearly injectable PrEP for HIV prevention in the United States.

The US Food and Drug Administration (FDA) has approved Gilead Sciences' injectable product, Yeztugo (lenacapavir), as a ...

DEP, the most common plasticiser in softgels, is considered to have relatively low toxicity and is used in small amounts. The ...

The 2025 Warren Alpert Foundation Prize has been awarded to three scientists whose discoveries culminated in the development ...

The World Health Organization (WHO) welcomes the approval by the United States Food and Drug Administration (FDA) of ...

Key Takeaways in this ArticleThe global Artificial Intelligence in Genomics market is valued at USD 785.12 million in 2024 ...

The US FDA has approved lenacapvir, sold under the brand name Yeztugo, as the first preventive treatment against HIV. It is a ...

Navigating the Artificial Blood Cells MarketIn the landscape of modern medicine, few innovations hold the transformative ...